Evidence map›Paper›PMID 26030747›Full record

ArticlePrimary psychiatry2009

Biologic Commonalities between Mental Illness and Addiction.

Karen J Hartwell, Bryan K Tolliver, Kathleen T Brady

Open access · greenAbstract read
In one paragraph

Article in Primary psychiatry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Karen J HartwellDrs. Hartwell and Tolliver are assistant professors, and Dr. Brady is professor and director of the Clinical Neuroscience Division, director of the South Carolina Clinical and Translational Research Institute, and associate dean for clinical research, all in the Department of Psychiatry and Behavioral Sciences in the Clinical Neuroscience Division at the Medical University of South Carolina's Ralph H. Johnson VA Medical Center in Charleston.
Bryan K TolliverDrs. Hartwell and Tolliver are assistant professors, and Dr. Brady is professor and director of the Clinical Neuroscience Division, director of the South Carolina Clinical and Translational Research Institute, and associate dean for clinical research, all in the Department of Psychiatry and Behavioral Sciences in the Clinical Neuroscience Division at the Medical University of South Carolina's Ralph H. Johnson VA Medical Center in Charleston.
Kathleen T BradyDrs. Hartwell and Tolliver are assistant professors, and Dr. Brady is professor and director of the Clinical Neuroscience Division, director of the South Carolina Clinical and Translational Research Institute, and associate dean for clinical research, all in the Department of Psychiatry and Behavioral Sciences in the Clinical Neuroscience Division at the Medical University of South Carolina's Ralph H. Johnson VA Medical Center in Charleston.
Ralph H. Johnson VA Medical Center · US

Funding

Interdisciplinary Women's Health Research at MUSCK12HD055885 · NICHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCGINTY, JACQUELINE F. · 2007 to 2021
$7.2M
Treatment of Alcohol Dependence and Co-Morbid Bipolar DisorderK23AA017666 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TOLLIVER, BRYAN K · 2009 to 2013
$1.1M
NIAAA NIH HHS K23 AA017666NICHD NIH HHS K12 HD055885
6 · The paper itself

Abstract

Epidemiologic studies indicate that co-occurring substance use disorders and psychiatric disorders are frequently found in clinical practice. From a neurobiologic perspective, what do these two seemingly different groups of disorders have in common? Currently, several hypotheses are postulated to explain the high rates of comorbidity. Chronic alcohol and drug use may lead to neuroadaptation in the biologic systems mediating psychiatric disorders. Conversely, co-occurring psychiatric and substance use disorders (SUDs) may represent phenotypic expressions of common premorbid neurobiologic abnormalities. Similar alterations in the dopamine-mediated reward system and various neurotransmitter systems including glutamate, γ-aminobutyric acid, and serotonin are found in both SUDs and numerous psychiatric disorders. Stress and chronic distress with the resultant activation of the hypothalamic-pituitary-adrenal axis and stress system has also been implicated in the pathophysiology of both psychiatric disorders and SUDs. Better understanding the commonalities between the two groups of disorders should lead to more efficacious treatments and targeted prevention strategies.

Identifiers

PMID26030747
PMCPMC3623011
OpenAlexW2135912639

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.